Pharmacy IV Solutions and Compounding Items

Stony Brook Medicine intends to purchase Pharmacy IV Solutions, Pharmacy Compounding Equipment and related items from Baxter against Premier agreements PP-IV-161 and PP-IV-1166 pursuant to their authority under section 163(3) (vi), which authorizes the purchase of commodities from a consortium or comparable entity in lieu of using a centralized contract and without a formal competitive process when justified by price. Vendors who sell the equivalent products may, if interested, contact the officer listed below to discuss the procurement. If GPO extends the agreement this agreement will run concurrent with those dates.

This procurement is subject to NYS Finance law 139 j&k, AKA the Lobbying law. Therefore, vendors are cautioned that the only permissible contact for this procurement is the individual listed below. Failure to comply with this requirement can range from no contract award to debarment from sales to any NYS Agency. Successful contractor shall be required to complete and submit documents related to Vendor Responsibility, NYS Finance law 139 j&k, and New York State’s Tax Law Section 5-a.

Successful contractor shall be required to submit valid and current NYS Workman’s Compensation and Disability Forms.

Anyone who believes they can provide these products are invited to contact Stony Brook University Hospital’s Purchasing Department as listed below.